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Retinoids are effective modulators of proliferation and dif-
ferentiation of keratinocytes in vivo and in vitro. In mouse 
10T1/2 cells, retinoid action on proliferation and neoplastic 
transformation is correlated with the upregulation of gap-
junctional communication and expression of connexin 43 
(Cx43). In the present study we have determined if retinoids 
induce similar effects on gene expression in human skin. 
Studies were conducted in intact skin and on cultured kerati-
nocytes and dermal fibroblasts. In a clinical study, 2 weeks of 
treatment with 0.05% all-trans retinoic acid resulted in in-
creased expression of Cx43 mRNA and protein in epidermis. 
Expression occurred predominantly in the suprabasal layer. 
Cultured cells exhibited a differential response to retinoic 
R etinoids, natural and synthetic compounds with v"itamin-A-like activity, have found extensive use in dermatology. Their action in most cases appears due to an alteration in the program of squamous differen-tiation in normal or diseased epithelium. In reconsti-
tuted human skin in culture, changes in the expression of specific 
keratins occur in response to retinoic acid [1]; this action is consist-
ent with its therapeutic effects on comedonal acne in humans [2] . In 
photoaged skin, retinoic acid increases the thickness of the epider-
mis in general, and the granular layer specifically [3]' Effects on 
dermal cells that could influence epidermal responses [4] have also 
been reported. The mechanism of action of retinoids on skin is not 
understood at the molecular level. However, the recent discovery of 
a family of nuclear receptors for retinoids (RAR), which have the 
capacity to modulate gene transcription by interactions with reti-
noid-responsive elements (RARE) in the regulatory regions of reti-
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Abbreviations: 
Cx43: connexin 43 
DMEM: Dulbecco's modified Eagle's medium 
EDT A: ethylenediaminetetroacetic acid 
FITC: fluorescein isothiocyanate 
RAR: nuclear retinoic acid receptor 
RARE: retinoic acid responsive elements 
SDS-PAGE: sodium dodecylsulfate-polyacrylamide gel electropho-
resIs 
TPA: tetradecanoyl phorbol acetate 
acid. In keratinocytes, increased expression of Cx43 occurred 
at low (10-11 M) concentrations, whereas inhibition occurred 
at high (10-7 M) concentrations; however, junctional com-
munication, measured by dye transfer, was not altered over 
this concentration range. Dermal fibroblasts, in contrast, ex-
hibited a dose-dependent increased expression of Cx4? at 
concentrations up to 10-7 M retinoic acid and proportion-
ately increased their junctional communication over this dose 
range. These data indicate that control of Cx43 gene expres-
sion by retinoids in human skin cells is complex. The produ~­
tion of gradients of junctional channels could playa rol.e 111 
the control of growth and differentiation in epidermiS. ] 
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noid-responsive genes, provides a likely explanation for the diverse 
effects of retinoids in multiple cells [5]. One such RAR (RARY), 
which is extensively expressed in human keratinocytes and dermal 
fibroblasts [6], has been described. It is not yet clear which genes are 
directly modulated by RARy in skin. . 
Retinoids are also active in epithelial tissues as cancer-prevent1~e 
agents. Premalignant lesions such as dysplasias of the uterine cerYlle 
[7] have been shown to regress after topical retinoic acid treatment. 
In patients at high risk for second primary malignancies of the head, 
neck, lung [8], and bladder [9]' the recurrence rate decreases after 
systemic retinoid treatment. 
For some years, we have been utilizing a model cell-culture sys-
tem of mouse embryo fibroblasts (10Tl/2 cells) to study mecha-
nisms of action of carcinogens and of cancer-preventive agents: In ' 
this cell line, neoplastic transformation can be induced in a quantita-
tive manner by chemical and physical carcinogens [10J. Moreover, 
retinoids can be shown to inhibit this process in vitro in a manner 
qualitatively and quantitatively similar to experimental animal sys-
tems [11]. In this model system, the ability of retinoids to surpre~s 
neoplastic transformation [12J and enhance growth controll~311~ 
highly correlated with their ability to upregulate gap_junctlOna 
intercellular communication. In 10Tl/2 cells, connexin 43 (Cx43) 
is constitutively expressed. This gene represents one member ~f a 
family of transmembrane proteins that are believed to assemble lfl(a 
hexameric array to line the water-filled pore composing one-half a 
hemiconnexon) of a junctional complex (a connexon) [14]. The 
other half of the connexon is donated by an adjacent cell. Gap 
junctions are found in most mammalian cells. Their functions are 
diverse and in general poorly understood. They are known to be 
responsible for the rapid transfer of ionic signals required for con-
traction of the heart and term myometrium [15] . There is eVidence 
for their role in the transfer of nutrients and excretory products In 
the avascular lens and cornea and for positional control in embry-
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onic development and tissue homeostasis [16,17]. We and others 
have proposed that they playa role in growth control [18,19]. The 
principal evidence for such a proposal comes from experiments dem-
onstrating that elevation of junctional communication is associated 
with enhanced growth control of normal or of neoplastic cells [18] 
and the inverse association of decreased communication with de-
creased growth control and malignancy [20]. As an example of the 
latter association, the potent skin-tumor promoter tetradecanoyl 
phorbol acetate (TPA) strongly inhibits junctional communication 
in cell culture [21]. whereas, the rodent liver promoter phenobarbi-
tal decreases expression of Cx32 in liver, the predominant junc-
tional protein found in this organ [22]. 
In mouse 10Tl/2 fibroblasts retinoids increase junctional com-
munication by upregulating expression of Cx43 at the protein and 
message level [23]. To determine if these results have relevance to 
retinoid action in humans, we have investigated the interaction of 
retinoic acid with connexin gene expression in human skin. Skin 
appears to be the major organ acutely affected by conditions of 
retinoid deficiency or excess [24] , and is known to express RAR [25] 
and also gap junctions [26]. Here we report that human skin ex-
presses Cx43 and that retinoic acid, applied in situ or to isolated 
keratinocytes or dermal fibroblasts, influences expression of this 
gene. These findings may have relevance to the proposed role of 
junctional communication in the control of growth and differentia-
tion. 
MATERIALS AND METHODS 
Clinical Studies Patients scheduled for elective plastic surgery 
were recruited into the study. They were asked to apply 0.05% 
retinoic acid cream (Retin-A) daily to an area of skin scheduled for 
removal 2 weeks later, and an equal quantity of placebo cream to a 
contralateral portion of skin (breast or abdomen) . Retin-A and pla-
cebo were kindly supplied by Johnson & Johnson. Patients gave 
their informed consent for this treatment. Consent forms and treat-
ment protocols were reviewed and approved by the Human Subjects 
Committee of the University of Hawaii. 
Excised skin was rapidly placed in a chilled sterile container and 
transported to the Cancer Center for processing. 
Cell Culture 
Human Keratinocytes: Normal human keratinocytes were isolated 
from newborn foreskin using a modified method by Wille et al [27] . 
The foreskin was cut into 5-mm pieces, and incubated in 25 units/ 
ml dispase solution overnight at 4 ° C. Epidermal sheets were sepa-
rated from dermis and digested in a 0.25% trypsin-ethylenediamin-
etetraacetic acid (EDTA) solution at 37"C for 30 min. The 
epidermal cells were suspended in serum-free keratinocyte medium 
(GIBCO) sup.flemented with epidermal growth factor (5 ng/ml), 
insulin (5 J-lgjml), and bovine pituitary extract (35 J-lg/ml). The 
keratinocytes were fluid changed with fresh complete medium 
every 72 h. Second-passage cells were grown to confluence and then 
treated with all-trans retinoic acid at the stated concentration or 
with acetone as control. 
Dermal Fibroblasts: Foreskins were chopped finely with scalpels 
and the small fragments were distributed in a series of culture dishes 
and cultured with Dulbecco's modified Eagle's medium (DMEM) 
supplemented with 10% fetal calf serum and 25 J-lg/ m! gentamicin. 
After about 10 d, when fibroblast outgrowth was extensive, the 
fragments were removed and regions showing a regular fibroblastic 
morphology were removed by ring-cloning. The dermal fibroblast 
strains were cultured in the above medium and cryopreserved at 
passage 2 for future use. Experiments were performed on confluent 
Cultures between passages 3 and 6. 
Measurement of Junctional Intercellular Communica-
tion Gap-junction - mediated intercellular communication was 
measured by microinjection of 10% Lucifer Yellow CH in 0.33 M 
LiCI as previously described [23]. The extent of intercellular com-
munication was determined by the number of fluorescent cells 
surrounding the dye-injected cell scored 10 min after dye injection. 
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Measurements were carried out in duplicate cultures in which about 
25 individual cells were probed/culture. 
Immunofluorescence Portions of surgically removed skin sam-
ples were cut into 5-mm pieces and placed in cold 10% buffered 
formalin solution for fixation. Fixed tissues were embedded in paraf-
fin, then subsequently sectioned (4 J-lm) and hydrated. Normal 
human keratinocytes and dermal fibroblasts were cultured on non-
fluorescent plastic slides (Permanox, Nunc Inc., Naperville, IL) 
until confluent. They were then treated with retinoic acid for 4 d. 
Double-immunofluorescence microscopy was performed as de-
scribed previously [23]. The slides were incubated for 30 min with a 
rabbit anti-Cx43 antibody (dilution 1:30) raised by immunization 
against a synthetic peptide representing the 'predicted final 15 resi-
dues of the C-terminal region of rat Cx43 [23] , then exposed to a 
fluorescein isothiocyonate (FITC) - conjugated second antibody 
(goat-anti-rabbit IgG, Fab). Some sections were exposed to rabbit 
preimmune serum, or to immune serum preabsorbed against the 
immunizing peptide, then to the second antibody to determine the 
specificity of binding of the primary antibody. Epifluorescence mi-
croscopy was performed using a Zeiss Axioplan and images were 
recorded on Kodak T-MAX film exposed at 6400 ASA. 
Total RNA Isolation RNA of control- and retinoic-acid-
treated skin samples was isolated after washing in cold PBS and the 
epidermis excised from dermis with a fine surgical razor. The epi-
dermal sheets were solubilized in 1 ml RNA Zol B solution (Bio-
Tecx) according to the procedures recommended by the manufac-
turer, with several strokes in a Tissumizer homogenizer. The 
homogenates were mixed with chloroform (10: 1) and placed on ice, 
then centrifuged at 12,000 Xg for 15 min. The upper aqueous 
phase containing RNA was precipitated with an equal volume of 
isopropanol at 4°C for for 45 min, followed by centrifugation at 
12,000 X g for 15 min. The RNA pellet was washed with 75% 
ethanol twice and air dried. The purified RNA was dissolved in 
sterile water. Quantitation and purity of the RNA was determined 
by UV spectroscopy at 260/280 nm. 
Northern Blotting Ten micrograms of total isolated RNA was 
subjected to Northern blot analysis as described previously [23]. 
RNA species were resolved by agarose gel electrophoresis and trans-
ferred to a nitrocellulose membrane. The membrane was hybridized 
with a[32P]-labeled full-length cDNA probe specific for rat heart 
connexin 43. Rat and human Cx43 exhibit 84% and 97% sequence 
homology at the nucleotide and amino acid level, respectively [28]. 
Western Blotting Extraction of connexin 43 protein from both 
skin samples and cultured cells was carried out as previously de-
scribed [23] . For skin samples, the epidermis was dissected away 
from the dermis and lysed in lysis buffer (1 % NP 40, 0.05 M iodo-
acetamide, 10 mM PMSF, 1 mM EDTA, 1 mM leupeptin, 2 mg/ 
mI aprotinin, and 0.7 mg/ml pepstain in borate buffer, pH 8.0) at 
4°C for 2 h. Cells were grown in 100-mm culture dishes, scraped 
off the dish in PBS (Ca++ and Mg++ free) with 1 mM NaF and 
1 mM PMSF, and pelleted by centrifugation. Cells were lysed in the 
above lysis buffer at 4 ° C for 1 h. After clarifying by centrifugation, 
the skin or celilysates, adjusted to contain equal protein concentra-
tions by the BCA protein assay solution (Pierce), were subjected to 
10% sodium dodecylsulfate - polyacrylamide gel electrophoresis 
(SDS-PAGE). Proteins were transferred onto immobilon mem-
branes (Millipore, Bedford, MA) by electroblotting, followed by 
blocking with 5% nonfat dry milk in PBS. The blots were incubated 
with anti-Cx43 antibody for 1 h, or as control, with immune serum 
pre-absorbed with the immunizing peptide, and washed in borate 
buffer. Antibody binding was detected with 1251-labeled protein A 
followed by autoradiography. 
RESULTS 
Cx43 is Expressed in Human Epidermis Skin samples ob-
tained during plastic surgery of adults or after routine neonatal 
circumcision were processed for molecular analysis or for immuno-
fluorescence. Indirect immunofluorescence analysis performed 
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Figure 1. Immunofluorescent localization of Cx43 in control and retinoic 
acid-treated human skin. Retinoic acid 0.05% (Retin-A) or placebo cream 
was applied to an area of skin on a daily basis for 14 d prior to scheduled 
removal during reconstructive or cosmetic surgery. Skin was fixed and pro-
cessed for indirect immunofluorescence using rabbit antiserum to the C-ter-
minal domain of Cx43 [23]. A: phase-contrast control skin. Bar, 50 p,. B: 
same section under epifluorescent optics. Note the annular fluorescent 
plaques surrounding cells in the suprabasal region of epidermis. Little or no 
specific fluorescence was noted in the basal and lower spinous layers .. C: 
phase-contrast treated skin. Note the increased thickness of the epidermis 
and lack of stratum corneum. D: epifluorescence view of C. Note the in-
creased intensity of fluorescence in the suprabasal region. E: higher-power 
view of the Cx43-expressing region of a different retinoic acid - treated skin 
sample. Fluorescent plaques clearly define regions of cell/cell contact. Bar, 
10 p,. F: epifluorescent micrograph of treated skin section labeled with 
pre-immune rabbit serum and FITC-labeled second antiserum. Note the 
background nuclear fluorescence in dermis and epidermis but lack of plaques 
in regions of cell contact. 
using a polyclonal antibody to Cx43 demonstrated that this anti-
body recognized plaques in regions of cell/cell contact of supra-ba-
sal cells of normal human epidermis. We did not detect any specific 
immunofluorescence in the dermis. (Fig lA,B). As a control, skin 
sections were incubated with primary antibody pre-absorbed with 
the immunizing peptide, to pre-immune rabbit serum, or to the 
secondary antibody only. No such .intercellular plaques were ob-
served in these controls (Fig 1 F). The primary antibody thus appears 
to specifically detect Cx43, a major portion of which is localized in 
regions of cell/cell contact, the expected location of gap-junctional 
plaques. By progressively focusing through the 4-Jlm skin section, it 
was observed that such plaques surrounded the antigen-positive 
supra-basal cells. No specific immunofluorescence was detected in 
basal or lower spinous keratinocytes in any of the multiple sections 
examined. 
The absence of antibody recognition of intercellular junctions in 
the basal cells was surprising because basal cells in situ and keratino-
cytes in culture, which are believed to represent the in vitro equiva-
lent of proliferating basal cells, are known to communicate. To 
determine if other members of the connexin family of molecules 
were expressed in basal cells, we performed indirect immunofluores-
cence using antibodies directed against mouse connexins 26 and 32, 
members of the connexin gene family known to be expressed in 
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organs other than the eye [29,30]. As a control, we utilized adult 
mouse liver in which both proteins are expressed [31]. We were 
again unable to detect specific immunofluorescence in basal cells, 
nor were these connexins detected in other cell types found in skin. 
Both antibodies detected the expected punctate pattern of junctions 
expected in liver (data not shown). 
Effects of Retinoic Acid on Expression of Cx43 We ha~e 
previously reported that retinoids upregulate junctional commUnI-
cation and expression of Cx43 mRNA and protein in a line of 
C3H/10Tl/2 mouse fibroblasts [23]. As skin is a major target of 
retinoids, we have investigated whether retinoids can also modulate 
expression of connexins in this organ. 
In Situ Studies: Skin samples were obtained from patients under-
going plastic surgery. Several patients consented to apply a 0.05% 
retinoic acid cream (Retin-A) twice daily to the area of the skin to be 
surgically removed. Treatment began 2 weeks before surgery. In 
several cases, patients had multiple episodes of cosmetic surgery 
performed on both sides of the body. In these cases, retinoic acid was 
applied to one side and a placebo cream to the contralateral side. 
Clinical Response to Retin-A: This short treatment duration and 
low concentration of retinoic acid (0.05%) produced no adverse 
reactions other than the expected mild erythema. In this respect, 
however, the treatments soon became unblinded to the patient. 
There were no reports of altered wound healing in retinoid-exposed 
areas. No patients withdrew from the protocol; on the contrary, 
several asked to again participate prior to subsequent surgery. 
Expression oJCx43 Gene Products: Skin samples were placed on ice 
immediately after surgery and were processed for immunofluores-
cence and for Northern and Western blotting using specific probes 
to Cx43 mRNA and protein as described above. Samples were cod~d 
so as not to reveal treated or control status. For molecular studies 
only the epidermis was examined. 
Cellular Location oj Cx43: Portions of skin were removed prior to 
molecular analysis and processed in parallel with control samples for 
immunofluorescence. Retinoic-acid - treated skin consisted of more 
epidermal layers (5 - 8 in controls to over lOin treated skin) and h~d 
lost the stratum corneum, as expected [32] (Fig Ie). Moreover, In 
the region of epidermis in which fluorescent intercellular plaques 
were visible fluorescence was more intense, plaques were in general 
more frequent, and more layers of epidermis expressed plaq~es 
(from about 2 in controls to 3 - 4 in treated skin) (Fig ID). SpeCific 
immunofluorescence in the dermis was again not observed. 
Western Blotting oj Epidermis: Equal amounts of protein derived 
from control and retinoic acid - treated skin were separated by SDS-
PAGE under reducing conditions, and the gels subjected to Western 
blotting using the same polyclonal anti-Cx43 antibody used. fOJ 
immunofluorescence. As shown in Fig 2, treated skin contall~e 
greater amounts of immunoreactive protein than control skin; Ill-
43-
1 2 3 4 
Figure 2. Increased expression of Cx43 in retinoic acid -treated humal 
skin. Equal amounts of protein extracted from the same treated and contrOd 
skin samples analyzed in Fig 3 were separated by SDS-PAGE and transferred 
to an immobilon membrane for Western blotting. The blot was incubated 
with polyclonal anti-Cx43 antibody, then with 125I-labeled protem': an f 
autoradiographed. Lane~ 1,2, treated skin; lanes 3,4, control skin. pOSitIOn ° 
a molecular weight marker in kD is shown. 
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Figure 3. Effects of retinoic acid on gene expression of Cx43 in human 
skin. RNA was extracted from retinoic acid-treated and control skin. Equal 
amounts of RNA (10 Ilg per lane) were electrophoresed, blotted, and hybrid-
ized against 32P-Iabeled Cx43 eDNA. Lane 1, retinoic acid - treated skin; lane 
2,3, control skin from two separate locations on the same patient. The RNA 
from the second treated site was lost. Comparable results were seen in the 
three other patients studied. Marker, calculated position of the 3.1-kD ex-
pected transcript size of Cx43 mRNA. 
deed, in controls, Cx43 was difficult to detect under the same con-
ditions of loading and labeling that yielded strong immunoreactive 
bands in treated skin. Commassie blue staining of blots for total 
protein revealed similar patterns and intensities (data not shown). 
This increased expression of Cx43 was consistently detected be-
tween subjects, and within an individual subject in one case where 
samples were obtained from discrete anatomic regions (usually 
breast and abdomen) after surgery separated by several months. 
Expression ofCx43 mRNA: Total RNA was extracted from treated 
and control skin, and identical amounts were separated by electro-
phoresis, prepared for Northern blotting, and probed with the full-
length cDNA for rat heart Cx43. Retinoid-treated skin exhibited a 
3.1-kb message that strongly hybridized to the Cx43 cDNA probe 
under stringent conditions (Fig 3) . This is the expected transcript 
size for Cx43 mRNA [14]. Other bands were not detected. RNA 
from placebo-treated skin gave only a weak signal, suggesting that 
in those cells expressing Cx43, the message is only transiently ex-
pressed or is very labile. 
These results demonstrated the expression of Cx43 gene products 
in human skin and the increased molecular abundance of gene prod-
ucts in the epithelial layer after only 2 weeks of treatment with 
retinoic acid. However, because the immunofluorescence studies 
indicated that the histologic region of epidermis in which Cx43 was 
expressed was also proportionally increased, increased Cx43 expres-
sion on a per cell basis could not be firmly established. Furthermore, 
the response of dermal fibroblasts was difficult to establish in the 
intact dermis where fibroblasts are distributed throughout a colla-
gen matrix. To overcome these difficulties, we initiated cultures of 
keratinocytes and dermal fibroblasts and investigated retinoid ef-
fects on Cx43 gene expression in these cultures. 
Expression of Cx43 in Cultured Skin Cells 
Keratinocytes: Cultures were obtained from neonatal foreskin 
using established techniques and cultured in semi-defined medium 
lacking an exogenous source of retinoids. When confluent, cells 
were treated with retinoic acid or acetone as control. Whole-cell 
lysates were separated by SDS-PAGE and prepared for Western 
blotting using the Cx43 antibody. As seen in Fig 4, control cultures 
exhibited a low basal level of expression of an immunoreactive 
43-Mr protein presumed to be Cx43. Expression of this protein 
exhibited a biphasic response to retinoic acid. High concentrations 
(10-7 -10-8 M) resulted in a decrease in expression of Cx43 protein, 
whereas lower concentrations (10-10 -10-11 M) caused a dose-re-
sponsive increase in expression. Staining of these blots with Coo-
massie Blue did not reveal any changes in the amounts of total 
protein in relevant regions of the gel, nor variations in the efficiency 
of protein transfer to the membrane (Fig 4, bottom). Pre-absorbed 
serum did not label this region of the blot. At the concentrations of 
retinoic acid used, no obvious changes in cell morphology resulted. 
Dermal Fibroblasts: Cultures of fibroblasts were established from 
neonatal foreskins, grown to confluence, then treated with retinoic 
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Figure 4. Induction of Cx43 by retinoic acid in cultured human keratino-
cytes, dose response studies. Confluent cultures of human keratinocytes 
were treated with retinoic acid (RA) or with acetone as control for 4 d. Cells 
were harvested and equal amounts of total cell protein subjected to SDS 
PAGE and Western blotting as in Fig 3. Top, lane 1, acetone control; lalle 2, 
RA 10-7 M; lalle3, RA 10-8 M; lane 4, RA 10-9 M;latle 5, RA 10-10 M; lane 6, 
RA 10-11 M; lane 7, RA 10-12 M. Bottom, same immobilon membrane 
stained with Coomassie Brilliant Blue to confirm that the protein loadings 
and transfer efficiency was approximately the same for each lane. Position of 
a molecular weight marker in kD is shown. Use of immune serum that had 
been preabsorbed with the immunizing peptide resulted in no labeling of the 
relevant 43-kD region of the blot (data not shown). 
acid or with acetone as control. After treatment with retinoic acid, 
the Cx43 bands increased in intensity. Staining of the blots with 
Coomassie Blue and subsequent digital analysis revealed that pro-
tein loading and electroblotting resulted in comparable (within 
20%) amounts of protein in each lane. Figure SB shows a Western 
blot that more clearly demonstrates the presence of two immunore-
A 
43-
43- ~ .. 
~ 
1 2 3 4 
B 
43-
1 2 3 4 
Figure S. A: Induction of Cx43 by retinoic acid in cultured human fibro-
blasts, dose response studies. Confluent cultures of human dermal fibroblasts 
were treated with retinoic acid or with acetone as control for 4 d using an 
identical protocol as employed in Fig 4. Equal amounts of total cell protein 
were subjected to SDS-PAGE and Western blotting as described above. Top, 
lane 1, acetone control; lane 2, RA 10-11 M; lalle 3, RA 10-9 M; lane 4, RA 
10-7 M. Bottom, same blot after staining with Coomassie Brilliant Blue as 
above. Quantitation of the heavily stained (approximately 35-kD) protein 
bands by digital analysis demonstrated that staining intensity did not differ 
by more than 20%. Position of a molecular weight marker in kD is shown. 
Use of pre-absorbed serum, as above, resulted in no labeling of the Cx43 
region of the blot. B: Western blot of cultured human dermal fibroblasts 
clearly demonstrating that Cx43 ran as a doublet on SDS-PAGE gel. Lanes 1 
alld 3, acetone control; lalles 2 and 4, retinoic acid 10-7 M . Treatment proto-
col as above. 
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Figure 6. Expression of Cx43 in cultured human dermal fibroblasts and 
epidermal keratinocytes. Cells from neonatal foreskins were cultured as 
described, treated with retinoic acid 10-7 M or with acetone as control for 
4 d, and subjected to indirect immunofluorescence staining essentially as in 
Fig 1. A and B, control fibroblasts, phase and fluorescence, respectively. Note 
occasional immunofluorescent plaques in regions of cell/cell contact. C Q/ld 
D, retinoic acid-treated fibroblasts, phase, and fluorescence, respectively. 
Regions of cell/cell contact are more clearly defined and junctional plaques 
are often fused into lines. E and F, keratinocytes, acetone control. Celllral cell, 
very infrequent junctional plaques observed in these cells. Bar, 10 fl. 
active protein bands in the 43- and 45-Mr region. The higher Mr 
form of the protein is believed to represent a phosphorylated form of 
Cx43. As previously observed in mouse lOT1/2 cells [23], the 
upper, presumably phosphorylated, species was greatly increased by 
retinoic acid treatment. 
Immunofluorescent Localization of Cx43 
Keratinocytes: Immunofluorescence microscopy demonstrated that 
immunoreactive protein was localized in regions of intercellular 
contact, consistent with the location of gap-junctional plaques. 
However, in control cultures, only about 10% of keratinocytes ex-
hibited detectable plaques (Fig 6E,F), whereas treatment with reti-
noic acid (10-7 M) reduced this frequency to about 2%, an observa-
tion consistent with the Western blots (data not shown). 
Fibroblasts: Control cultures of confluent fibroblasts exhibited fre-
quent immunoreactive plaques in regions of cell/cell contact (Fig 
6A,B). Retinoic acid (10-7 M) caused an increase in the number and 
apparent size of these plaques. Whereas, in controls, plaques were 
punctate and discrete, plaques in treated fibroblasts tended to co-
alesce into lines that demarcated cellular peripheries (Fig 6C,D). 
Retinoic Acid Effects on Junctional Communication: Both types of 
cells communicated well in monolayer culture as measured by dye-
transfer studies (Fig 7). However, cells differed in their response to 
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retinoic acid; whereas dermal fibroblasts were found to increase the 
extent of dye-transfer over the dose range tested (10-11 - 1 0-7 ~), 
keratinocytes, in contrast, did not change over this concentratton 
range. Plotted in Fig 7 are estimates of Cx43 expression in these twO 
cell types as influenced by retinoic acid (data obtained by densitome-
try of Western blots shown in Figs 4,5). It is apparent that in fibr?-
blasts the molecular measurements of Cx43 expression and Its 
modulation by retinoic acid are consistent with functional measure-
ments of gap-junctional communication; however, in keratinocytes 
this relationship does not hold. For example, the decrease in expres-
sion of Cx43 observed at 10-7 M retinoic acid (Fig 4) was n~t 
accompanied by a proportional decrease in dye transfer. photomI-
crographs of representative cells probed by microinjection of L~­
cifer Yellow are shown in Fig S. The increase spread of dye In 
10-7 M retinoic acid - treated fibroblasts (Fig SB versus 8D) con-
trasts with the unaltered dye transfer seen in treated keratinocytes 
(Fig SF versus SR). These results suggest the amount of Cx43 is .not 
a rate-limiting step for dye transfer in keratinocytes. A pOSSible 
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Figure 7. Top, effects of retinoic acid on gap-junctional communication in 
keratinocytes and dermal fibroblasts. Keratinocytes and dermal fibroblasd were grown to confluence as described in Materials otld Methods, and teeate 
with retinoic acid or acetone as control for 4 d. Individual cells were then 
probed by microinjection of the junctional permeable fluorescent dye Lu-
cifer Yellow CH as described, and the number of adjacent cells that beca~e 
fluorescent within approximately 10 min of injection were counted. Consist-
ent results were obtained on two batches of cells. Results show a represen.ta-
tive experiment in which about 45 cells in each dosage group were microm-
jected. Data points, means ± SD. For fibroblasts, all treatment groupS ~ere 
significantly different from acetone-treated controls (p < 0.001). Retlnolc 
acid induced no significant changes in keratinocyte cultures. Bottom, qUal1t1ci 
tation of Cx43 in retinoic acid - treated cultures of dermal fibroblasts an 
keratinocytes. Data, expressed as arbitrary units of optical density, we~e 
obtained by digital quantitation of the Western blots shown in Figs 4 an~ i 
In both experiments, cui tures were exposed to retinoic acid using identlca 
protocols. The concordance between Cx43 expression and junctional co.m-
munication in fibroblasts contrasts with the apparent lack of correlation 
between these two parameters in keratinocytes. 
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Figure 8. Junctional communication assays in human fibroblasts and kerati-
nocytes. Left, phase-contrast images; right, epifluorescent images after mi-
croinjection of Lucifer Yellow. A atld B, fibroblasts, acetone control. C atld 
D, fibroblasts, retinoic acid 10-7 M. E atld F, keratinocytes, acetone control. 
G arId H, keratinocytes, retinoic acid 10-7 M. Treatment protocol as for Fig 
7. Bar, 50/1. 
explanation for these observations is that Cx43 is not assembled in 
the cell membrane of most keratinocytes and thus not functional 
and not detectable by immunofluorescence because of the high 
background fluorescence of these cells (Fig 1F). 
DISCUSSION 
Retinoids are effective modulators of proliferation and differentia-
tion of keratinocytes in vivo and in vitro [33]. This activity is pre-
sumably responsible for their clinical usefulness in a wide range of 
diseases of the skin characterized by abnormal differentiation [34]. 
The epidermal cells respond to retinoids by suppressing terminal 
differentiation. This has been characterized at the molecular level as 
a decreased expression of keratins associated with normal terminal 
differentiation. Little is known of the mechanisms by which kerati-
nocytes regulate their differentiation, and less of how retinoids af-
fect this complex process. Most evidence points to the existence of a 
gradient of signals, from the basal cells up, which triggers the se-
quential differentiation of these cells. Ca++ has been shown to pos-
sess the required characteristics; a gradient exists in the epidermis 
[35] and cultured keratinocytes undergo terminal differentiation in 
response to high Ca++ levels [36]. How might a gradient of this or 
other psysiologic regulator be maintained and controlled? Similar 
questions face investigators with interest in morphogenesis and 
growth control. The diffusion of regulators via gap junctions from 
cytoplasm to cytoplasm appears to offer many advantages of control, 
both in concentration and direction, over diffusion via the extracel-
lular space. The observations that during embryogenesis junctional 
communication is compartmentalized to cell groups with similar 
destinies [37], that gradients of junctions exist in the developing 
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chick limb bud [17], and that junctional communication in mouse 
and human skin appears restricted to vertical compartments [26,38] 
all suggest a role for junctional communication in the local control 
of growth and differentiation. 
In previous studies using 10T1/2 cells as a model system to inves-
tigate retinoid action, we demonstrated that natural and synthetic 
retinoids that possessed the capacity to maintain the normal differ-
entiation of hamster tracheal cells (i.e. those with vitamin-A-like 
activity) would suppress chemically induced neoplastic transforma-
tion [12] and enhance growth control [13]. These two phenomena 
were later found to be tightly correlated with the ability of retinoids 
to upregulate gap-junctional intercellular communication [39] , 
driven by a major increase in Cx43 expression [23]. In the present 
study we have extended these observations to human cells and have 
demonstrated that retinoic acid, applied either topically in vivo or to 
cultured skin cells in vitro, elevated Cx43 expression in normal 
human keratinocytes and dermal fibroblasts. In the latter cells, just 
as in the model mouse cells, retinoic acid also elevated gap-junc-
tiona I communication. 
Gap junctions are ubiquitous, are found in virtually all adult and 
embryonic tissues in mammals, and constitute a family of proteins 
whose members are still being described [40]. These connexin mole-
cules differ primarily in the length and sequence of their cytoplasm-
orientated C-terminal regions . This report is the first to demon-
strate expression of a specific connexin (Cx43) in the intact human 
epidermis and modulation of its expression by retinoids, although 
Cx43 was recently found in cultured mouse keratinocytes [41] and a 
novel connexin (Cx31) has been reported in whole mouse skin [42]. 
However the existence of gap junctions in skin has been known for 
some time, since Elias and Friend [43] revealed their presence by 
e1ectronmicroscopy and showed that retinoic acid altered their dis-
tribution. In human squamous cell carcinoma, retinoic acid was 
reported to cause a proliferation of gap junctions [44], a finding that 
may be germane to the present observations of increased expression 
of Cx43 in suprabasal cells, because this tumor represents the malig-
nant conversion of such cells. Junctional transfer of microinjected 
dye has been demonstrated by others [26] in intact human skin 
obtained after removal by keratome. In accord with predictions of 
the present study, suprabasal cells were much more extensively cou-
pled than were basal cells, although both cell layers were coupled. 
No evidence for coupling between basal and dermal cells was found, 
although dermal cells were highly coupled. It is of interest that no 
statistically significant change in dye transfer between keratinocytes 
was recorded in skin samples obtained from retinoid-treated skin; 
however, mean values in skin treated topically with retinoic acid 
were twice as high as controls [26]. Madhukar et al [45] showed that 
TGF-fi blocked gap-junctional communication in cultured human 
epidermal keratinocytes and induced terminal differentiation. The 
disruption of cellular communication led to the isolation of differ-
entiated cells from as-yet undifferentiated cells. Gap-junctional 
communication in human keratinocytes is also inhibited by tumor 
promoters [21]. Retinoids are considered to be antipromoters 
[11 ,46,47], and they also inhibit calcium-induced differentiation of 
human keratinocytes [48]. Furthermore, the effects of retinoids and 
TGF-fi on hyperproliferation of human skin cells are antagonistic. 
[49]. These data are all suggestive that one pathway for retinoic acid 
action on keratinocyte differentiation is mediated through gap-
junctional communication. 
In skin treated topically with retinoic acid, the increased expres-
sion of Cx43 was present mainly in the suprabasal layer of the 
epidermis. This was associated with the thickening of the epidermal 
layer and the disappearance of the keratinized layer (Fig 1). The 
thickening of the epidermis appears due to the effects of retinoic 
acid on inhibiting differentiation [1] and/or promoting prolifera-
tion [4,50]. The increase in Cx43 expression detected at the molecu-
lar level (Figs 2,3) could result from an increase in the Cx43 level 
per cell, or, alternatively, from an increase in the number of cells 
expressing Cx43. On the basis of our observations in intact skin, we 
were not able to differentiate between these alternatives. To do so 
we examined the effects of retinoic acid on expression of Cx43 and 
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on junctional communication in cultured skin cells. Although Cx43 
was detected in both keratinocytes and fibroblasts, these cells dif-
fered qualitatively and quantitatively in their responses to retinoic 
acid. Cultured keratinocytes, when maintained in low-calcium me-
dium, retain proliferative capacity and the majority do not termi-
nally differentiate. In these respects, they resemble basal cells in situ 
[36]; the infrequent expression of Cx43 in both situations strength-
ens this interpretation. The reported ability of retinoic acid to in-
hibit keratinocyte differentiation [48] suggests that those 10% cells 
in which Cx43 was detectable by immunofluorescence were under-
going terminal differentiation and that 10-7 M retinoic acid inhib-
ited expression of Cx43 (Fig 4) by inhibiting this process. At very 
low concentrations (10-11 M) retinoic acid increased Cx43 expres-
sion, whereas higher concentrations (10-7 _10- 8 M) decreased ex-
pression (Fig 4). However, we could find no change in communica-
tion over the entire dose range tested (Fig 7). In contrast, dermal 
fibroblasts increased their expression of Cx43 and their transfer of 
dye at high, but not low, concentrations of retinoic acid. These 
results suggest that skin cells may differentially express specific 
high-affinity receptors for retinoic acid. In contrast to the frequent 
immunofluorescent plaques seen in cultured dermal fibroblasts, 
such plaques were not detected in situ. We attribute this to the low 
probability of sectioning through a region of intercellular contact in 
the dermis. 
It has been shown that retinoic acid can directly bind to nuclear 
receptors (RAR) [51, 52], which in turn can control the transcrip-
tion of differentiation-specific genes by binding to specific DNA-
response elements (RARE). Expression of two retinoic acid recep-
tors (RARa and y) has been described in human skin [6]. RARy is the 
predominant receptor expressed in both dermis and epidermis. 
RARa is also constitutively expressed in both tissues and is located 
mainly in the suprabasal cells of the epidermis [53] . It is of interest 
that RARP is not constitutively expressed in either cell type but is 
inducible by retinoic acid in dermal fibroblasts but not in keratino-
cytes in culture [6] . This cell type specificity for induction mirrors 
the current observation for Cx43 induction. This difference be-
tween dermal and epidermal cells in their sensitivity to retinoid 
treatment may be due to: i) lower expression, or differential induc-
tion, of RAR in dermal cells than in epidermal cells; ii) differential 
expression of cellular receptors for retinoic acid (CRABP) [54]. 
which modulate levels of unbound drug; or iii) the rich blood sup-
ply in the dermis, the only source of retinoids for the epidermis, 
which may also in part contribute to this differential sensitivity by 
producing a concentration gradient of retinoids in skin from dermis 
to epidermis. 
Although Cx43 is a major gap-junctional protein presumably 
responsible for gap-junctional intercellular communication in su-
prabasal epidermal cells [41], the evidence indicates that other mem-
bers of the connexin family of junctional proteins may be expressed 
in basal cells and cultured keratinocytes, which in proliferative ca-
pacity and differentiated phenotype closely resemble basal cells [36]. 
Our observation of no significant change in intercellular communi-
cation in cultured keratinocytes in response to retinoid treatment, in 
spite of major changes in Cx43 expression, in a positive and negative 
direction, and our failure to detect Cx43 expression in basal cells of 
intact skin both point to this conclusion. Other connexin proteins, 
such as Cx31, may be involved in gap-junctional communication in 
basal keratinocytes. These proteins too may be regulated by reti-
noids, adding further complexity to the modulation of epidermal 
differentiation. 
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